Influenza Vaccination and Cardiovascular Disease
Evidence from several studies indicates that annual vaccination against seasonal influenza prevents cardiovascular morbidity and all-cause mortality in patients with cardiovascular conditions. Studies indicate that the influenza vaccine almost halves the risk of heart attacks in older adults. The Influenza Specialist Group recommends influenza immunization after admission for Acute Coronary Syndromes (ACS) and as part of comprehensive secondary prevention in persons with coronary and other atherosclerotic vascular disease.
Healthcare providers who treat individuals with cardiovascular disease can help improve influenza vaccination coverage rates by providing and strongly recommending vaccination to their patients before and throughout the influenza season.
Page published: January 2014
Last reviewed: 7 October 2015